Telemedicine | Virtual Rehab Center (MIA-VRTM)
Access to Online Addiction Treatment
Welcome to our virtual treatment center (Now serving Missouri, Illinois, and Kansas).
We know that much of rural America goes without adequate medical, psychiatric, and behavioral care but not the problems that require this care in the first place. For this reason, MIA has established its virtual rehab center (often known as telemedicine) to treat the ongoing struggle with opiates, alcohol, and other mood-altering substance abuse and dependency issues.
What is MIA-VRTM? Because this type of program is new to most individuals a detailed outline is provided below:
Virtual Rehabilitation/Telemedicine (VRTM)
Our VRTM program includes more than just physician visits, it is designed to provide holistic behavioral health and substance abuse treatment for those who have circumstances that prohibit their ability to attend traditional treatment programs.
Those substance use services that are rendered via teleconferencing through an encrypted platform appropriate to the provision of service for clients to gain the knowledge, insight, coping mechanisms, and support systems necessary to achieve and maintain long-term recovery and improve their quality of life by integrating MIA-VRTM services with those in their community.
Outpatient Substance Use medication management is the level of outpatient treatment where the primary service rendered is by a qualified prescribing provider who evaluates the individual’s need for medications to assist in detoxification or sobriety, provides prescriptions, and ongoing medical monitoring. These services can include outpatient detoxification and maintenance medications that are used in conjunction with other necessary self-directed, peer support or professional services. MIA provides these services in a way that is confidential, private, safe, comfortable, and facilitates the recovery, wellbeing, and self-efficacy of the persons served.
Laboratory testing is used in the initial assessment and ongoing monitoring of drug and alcohol treatment compliance. Ambulatory laboratory testing for drugs of abuse is a medically necessary and useful component of chemical dependency treatment. Drug tests results are of importance in treatment programs and in outpatient chemical dependency treatment. MIA will test clients in-person during their initial visit and yearly visit while interim testing will be required at an MIA approved clinic within the client’s geographic area.
Abstinence from all non-prescribed mood altering substances. Physical wellbeing and detoxification from abused chemicals. Maintenance of homeostasis and removal of withdrawal symptoms. The inclusion of psychiatric and behavioral components of care and pharmacological therapy for craving control and euphoric inhibition. Treatment for co-occurring psychiatric disorders and co-morbidities. The inclusion of family and/or support system when applicable (as permitted). Promotion of recovery and well-being and self-resilience of the person served. Gaining the knowledge, insight, coping mechanisms, and support systems necessary to achieve and maintain long-term recovery and improved quality of life. Appropriate transition to maintain the benefits of treatment.
All limitations inherent in the traditional physician-patient relationship are present in telemedicine. Persons served may need to visit their primary care physician prior to any treatment with medications. Not all consultations will result in the prescription of medication. When indicated, prescriptions can be sent (electronically, via fax, or by phone) to the patient’s pharmacy of choice. However, some states and federal laws provide stipulations when prescribing Schedule II, III, IV and V medications. For buprenorphine (Suboxone, Zubsolv, Bunivail, Subutex) treatment through this program, clients are required to have an initial and yearly Face-to-Face visit as well as random drug testing at a facility of MIA’s choosing upon request and on a regular basis. Follow-ups for all scheduled medications must be conducted through video. The physician may require additional visits and labs be done and are purely up to the prescribing physician. This may vary state to state and some state laws do not require the initial face to face visit.
These services are typically no more than 2-5 hours a week. Active family/significant other involvement is important unless contraindicated. The goals, frequency and length of treatment will vary according to the needs of the individual and the response to treatment. A clear treatment focus, measurable outcomes, and a discharge plan (including the identification of realistic discharge criteria) is developed as part of the initial assessment and treatment planning process and is evaluated and revised as necessary as treatment proceeds. Outpatient services may be of brief duration and may be provided as a step down from a higher intensity of care or as initial treatment. Some individuals, however, may require ongoing, intermittent contact with a licensed professional (e.g. once or twice per month) and other resources in their community past VRTM treatment to maintain the individual’s optimal level of functioning, sobriety, and to prevent the need for more intensive levels of care. Medical and Psychiatric consultation is available based on clinical need.
- Contact hours (GOP)
- VRTM is not clinically appropriate for individuals as a stand-alone program/service. VRTM is designed to complement the facilitation of local mental health clinic services and community resources for the persons served and is facilitated through the case manager and treatment plan. All program requirements are person-centered, determined at assessment, and continues through ongoing treatment planning and assessment.
- Services are conducted via a telemedicine platform between direct service staff within MIA facilities and the persons served at secure locations of their choosing. It is the responsibility of the client to ensure that their sessions are private and the technology and data transmission are secure.
- When applicable and permitted, the program coordinates with other area services
- Services are offered at times that maximize the ability of the person served to participate
- Admission is determined by a qualified behavioral health practitioner during the initial face-to-face sessions that include a full evaluation by a behavioral health specialist, physician, and laboratory tests.
- Review of individualized plan occurs at least once per month
- Services and Modalities:
- Face-to-face Initial Visit (Medical Doctor)
- Virtual – Pharmacological Therapy: applicable to opiate, alcohol, benzodiazepine, and other chemical detox. (Medical Doctor)
- Virtual – Medication Management (Medical Doctor)
- Ongoing virtual physician evaluation (Medical Doctor)
- Virtual Psychiatric Evaluation (Board certified psychiatrist)
- Ongoing virtual psychiatric care (Board certified psychiatrist or psychologist)
- Toxicology Screening and other pertinent laboratory testing (authorized personnel at local facilities approved by MIA)
- MIA Addiction Severity Index (clinical staff & psychotherapist)
- 24-hour contact (On-call therapist & Medical Doctor)
- Pharmacological Therapy: applicable to the maintenance of sobriety, control of cravings, and inhibition of euphoric “highs”.
- Virtual Case Management
- Individual therapy, family therapy, group therapy, and other behavioral components are facilitated through client’s community resources.
Contact our office today to schedule your initial visit. You will need to allow most of the day to complete all of the required initial services:
- Medical Visit
- Lab Testing
You will need to ensure you bring:
- Photo I.D.
- Current Insurance Card
- Payment (must be credit or debit card of individual attending or present with the client)
It is recommended that clients travel with loved ones, as operating a motor vehicle may be contraindicated in the client’s state during this period.